Skip to main content
A-Z IndexCalendarsDirectoryMaps

West Virginia University

WVU announced plans for on-campus classes this fall, with base tuition and fees unchanged. Visit the Return to Campus website for the latest.

A Stronger Tomorrow Starts Today

As we work hard to adapt and prep WVU for in-person instruction this fall, one thing will never change — our commitment to providing an incredible education while looking out for the health and safety of all Mountaineers. And WVU President E. Gordon Gee is calling on all of us to help build a safer, even stronger community.

Read President Gee’s Message Return to Campus Website

Register for Virtual New Student Orientation

Prepare for your first day (and beyond). Register now.
Have questions about NSO? We have answers.

Resources to Launch Your Journey

We're here to help every step of the way.

Future Student Resources

Whether you're just researching or you're ready to apply, you can start here to learn more.

Visit the Future Student Resources website

Admitted Student Resources

Already admitted to WVU? No matter where you are, you can explore campus, get your questions answered and immerse yourself in our one-of-a-kind community.

Visit the Admitted Student Resources website →

Family Resources

If your student's been admitted to WVU, we know you have questions, too. Learn about next steps, student services and how to connect with other parents and families.

Visit the Family Resources website

Graduate Admissions

Explore our 220 graduate programs, estimate costs, review application procedures and apply online. Want to learn even more? You can take a virtual tour to explore our facilities.

Visit the Graduate Admissions website
Portrait of Brian Peppers
Research and Innovation Student Profiles | Faculty Profiles

Breaking New Ground in COVID-19 Immunotherapy

Brian Peppers

WVU Medicine pediatric and adult allergist and immunologist Brian Peppers, DO, PhD, has received Investigational New Drug approval from the U.S. Food and Drug Administration for the experimental treatment of COVID-19 using convalescent donor plasma.

It’s the first FDA approved Investigational New Drug trial for COVID-19 immunotherapy to include pediatric patients.